Immunopathology of specific cancers in males and females and immunotherapy of prostate and cervical cancer

Maurizio Chiriva-Internati, Fabio Grizzi, Gianluigi Taverna, Leonardo Mirandola, Scott W. Dahlbeck, Marjorie R. Jenkins, Diane D. Nguyen, Martin J. D’Souza, Everardo Cobos, Jose A. Figueroa

Research output: Chapter in Book/Report/Conference proceedingChapter


Cancer remains one of the most complex diseases affecting humans, and despite the impressive advances that have been made in molecular and cell biology, how cancer cells progress through carcinogenesis and acquire their metastatic ability is still widely debated. Prostate cancer emerges from multiple alterations that induce changes in expression patterns of genes and proteins that function in networks controlling critical molecular and cellular events. Based on the exponential aging of the population and the increasing life expectancy in industrialized Western countries, prostate cancer is becoming a disease of increasing significance. While the incidence of cervical cancer has declined significantly in the USA, ethnic disparities remain in terms of increased mortality and morbidity. Here, it is aimed to review the clinical experiences and results achieved with immunotherapy for treating prostate and cervical cancers, two of the most significant malignancies in human male and females, respectively.

Original languageEnglish
Title of host publicationCancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
PublisherSpringer Berlin Heidelberg
Number of pages12
ISBN (Print)9783662464106, 9783662464090
Publication statusPublished - Jan 1 2015


  • Cancer
  • Cervix
  • Immunity
  • Immunotherapy
  • Prostate

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)


Dive into the research topics of 'Immunopathology of specific cancers in males and females and immunotherapy of prostate and cervical cancer'. Together they form a unique fingerprint.

Cite this